SCHEMBL5309729

SCHEMBL5309729

NS(=O)(=O)c1ccc(N=Cc2ccc(F)cc2F)cc1

nearest known ligand 0.64

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 16/20 0.64
▸ CA1 P00915 15/20 0.64
▸ CA9 Q16790 14/20 0.64
▸ CA12 O43570 10/20 0.64
▸ PTGS2 P35354 6/20 0.64
▸ PTGS1 P23219 3/20 0.64
▸ CA7 P43166 4/20 0.60
▸ ACHE P22303 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5309725 1.00 CA2 (0.64) CA2CA1CA9CA12PTGS2
SCHEMBL11406653 0.82 GRIN2D (0.53) CA2CA1CA9CA12PTGS2
SCHEMBL11406654 0.82 GRIN2D (0.53) CA2CA1CA9CA12PTGS2
SCHEMBL5311683 0.78 PTGS2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL5312313 0.78 PTGS2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL5311687 0.78 PTGS2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL5312314 0.78 PTGS2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL19967365 0.76 GRIN2D (0.47) CA2CA1CA9CA12PTGS2
SCHEMBL11404562 0.76 NFE2L2 (0.52) PTGS2ACHE
SCHEMBL11404558 0.76 NFE2L2 (0.52) PTGS2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799823-B1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses DAIICHI SANKYO CO LTD (JP) 2007-10-31 — — EP disclosed
US-RE39420-E1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 2006-12-05 — — US disclosed
US-5908858-A OSTEOPOROSIS; LEUKOTRIENE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1999-06-01 — — US disclosed
EP-0799823-A1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1997-10-08 — — EP disclosed
Send feedback